The Brief
What Flatiron Health Oncology does and why it matters
Flatiron Health curates real-world oncology data from 3 million cancer patients to power AI research for drug development and clinical insights. Acquired by Roche to accelerate cancer treatment discovery.
Builder’s Brief
Flatiron Health Oncology is a healthcare tool on Falcoscan. AI real-world evidence platform for oncology research. Falcoscan rates Flatiron Health Oncology with an Opportunity score of 84/100, a Saturation score of 8/100, and a Wrapper-risk score of 6/100. Market signal: hot. Flatiron Health Oncology is founded in 2012, currently at Public stage. Pricing: Paid. Rating 4.6/5 across 1 tracked views.